Regenicin Stock Volatility
| RGIN Stock | USD 0.0003 0.00 0.00% |
Regenicin is out of control given 3 months investment horizon. Regenicin maintains Sharpe Ratio (i.e., Efficiency) of 0.14, which implies the firm had a 0.14 % return per unit of risk over the last 3 months. We were able to collect and analyze data for sixteen different technical indicators, which can help you to evaluate if expected returns of 3.28% are justified by taking the suggested risk. Use Regenicin Risk Adjusted Performance of 0.1069, variance of 514.34, and Coefficient Of Variation of 712.77 to evaluate company specific risk that cannot be diversified away.
Sharpe Ratio = 0.1425
| High Returns | Best Equity | |||
| Good Returns | RGIN | |||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average Regenicin is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Regenicin by adding it to a well-diversified portfolio.
Key indicators related to Regenicin's volatility include:30 Days Market Risk | Chance Of Distress | 30 Days Economic Sensitivity |
Regenicin Pink Sheet volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Regenicin daily returns, and it is calculated using variance and standard deviation. We also use Regenicin's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Regenicin volatility.
Regenicin |
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Regenicin can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Regenicin at lower prices. For example, an investor can purchase Regenicin stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of Regenicin's stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns. Main indicators related to Regenicin's market risk premium analysis include:
Beta 3.07 | Alpha 2.89 | Risk 23.03 | Sharpe Ratio 0.14 | Expected Return 3.28 |
Moving together with Regenicin Pink Sheet
| 0.67 | VRTX | Vertex Pharmaceuticals | PairCorr |
| 0.67 | WF | Woori Financial Group | PairCorr |
| 0.61 | ACN | Accenture plc | PairCorr |
| 0.73 | ATI | Allegheny Technologies | PairCorr |
| 0.66 | MRK | Merck Company | PairCorr |
| 0.67 | JPM | JPMorgan Chase | PairCorr |
Moving against Regenicin Pink Sheet
| 0.64 | ALNY | Alnylam Pharmaceuticals | PairCorr |
| 0.42 | ARGX | argenx NV ADR | PairCorr |
| 0.4 | BKRKF | PT Bank Rakyat | PairCorr |
| 0.39 | PBCRF | PT Bank Central Earnings Call This Week | PairCorr |
| 0.39 | PBCRY | Bank Central Asia Earnings Call This Week | PairCorr |
Regenicin Market Sensitivity And Downside Risk
Regenicin's beta coefficient measures the volatility of Regenicin pink sheet compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Regenicin pink sheet's returns against your selected market. In other words, Regenicin's beta of 3.07 provides an investor with an approximation of how much risk Regenicin pink sheet can potentially add to one of your existing portfolios. Regenicin is displaying above-average volatility over the selected time horizon. Regenicin appears to be a penny stock. Although Regenicin may be, in fact, a solid short-term or long term investment, many penny pink sheets are speculative investment instruments that are often subject to artificial stock promotion and campaigns of hype which may lead to misinformation and misrepresentation. Please make sure you fully understand upside potential and downside risks of investing in Regenicin or similar risky assets. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswing without any event/news,and sudden news releases. We also encourage traders to check biographies and work history of company President, CEO or other officers before investing in high-volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Regenicin instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.
3 Months Beta |Analyze Regenicin Demand TrendCheck current 90 days Regenicin correlation with market (Dow Jones Industrial)Regenicin Volatility and Downside Risk
Regenicin standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Regenicin Pink Sheet Volatility Analysis
Volatility refers to the frequency at which Regenicin pink sheet price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Regenicin's price changes. Investors will then calculate the volatility of Regenicin's pink sheet to predict their future moves. A pink sheet that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A pink sheet with relatively stable price changes has low volatility. A highly volatile pink sheet is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Regenicin's volatility:
Historical Volatility
This type of pink sheet volatility measures Regenicin's fluctuations based on previous trends. It's commonly used to predict Regenicin's future behavior based on its past. However, it cannot conclusively determine the future direction of the pink sheet.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for Regenicin's current market price. This means that the pink sheet will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Regenicin's to be redeemed at a future date.Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Regenicin Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.
Regenicin Projected Return Density Against Market
Given the investment horizon of 90 days the pink sheet has the beta coefficient of 3.073 indicating as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Regenicin will likely underperform.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Regenicin or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Regenicin's price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Regenicin pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Regenicin has an alpha of 2.8942, implying that it can generate a 2.89 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Predicted Return Density |
| Returns |
What Drives a Regenicin Price Volatility?
Several factors can influence a pink sheet's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.Regenicin Pink Sheet Return Volatility
Regenicin historical daily return volatility represents how much of Regenicin pink sheet's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The firm inherits 23.0289% risk (volatility on return distribution) over the 90 days horizon. By contrast, Dow Jones Industrial accepts 0.6944% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Regenicin Pink Sheet performing well and Regenicin Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Regenicin's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| VOQP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| QBIO | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| SCPS | 6.18 | 1.25 | 0.00 | 2.17 | 0.00 | 33.33 | 83.33 | |||
| PARD | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| AOLS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| RCAR | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| OZYMF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| NNLX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| VAXX | 1,986 | 1,140 | 13.39 | 12.09 | 170.70 | 14,900 | 15,000 | |||
| XSNX | 3.52 | 0.07 | 0.00 | 0.07 | 0.00 | 0.00 | 150.00 |
About Regenicin Volatility
Volatility is a rate at which the price of Regenicin or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Regenicin may increase or decrease. In other words, similar to Regenicin's beta indicator, it measures the risk of Regenicin and helps estimate the fluctuations that may happen in a short period of time. So if prices of Regenicin fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.Regenicin, Inc. focuses on developing and commercializing a technology of tissue-engineered skin substitutes. Regenicin, Inc. was incorporated in 2007 and is headquartered in Little Falls, New Jersey. Regenicin operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 3 people.
Regenicin's stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Regenicin Pink Sheet over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Regenicin's price varies over time.
3 ways to utilize Regenicin's volatility to invest better
Higher Regenicin's stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Regenicin stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Regenicin stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Regenicin investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in Regenicin's stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of Regenicin's stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Regenicin Investment Opportunity
Regenicin has a volatility of 23.03 and is 33.38 times more volatile than Dow Jones Industrial. 96 percent of all equities and portfolios are less risky than Regenicin. You can use Regenicin to protect your portfolios against small market fluctuations. The pink sheet experiences a normal downward fluctuation but is a risky buy. Check odds of Regenicin to be traded at $3.0E-4 in 90 days.Significant diversification
The correlation between Regenicin and DJI is 0.09 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Regenicin and DJI in the same portfolio, assuming nothing else is changed.
Regenicin Additional Risk Indicators
The analysis of Regenicin's secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Regenicin's investment and either accepting that risk or mitigating it. Along with some common measures of Regenicin pink sheet's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | 0.1069 | |||
| Market Risk Adjusted Performance | 1.04 | |||
| Mean Deviation | 7.38 | |||
| Coefficient Of Variation | 712.77 | |||
| Standard Deviation | 22.68 | |||
| Variance | 514.34 | |||
| Information Ratio | 0.1359 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential pink sheets, we recommend comparing similar pink sheets with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Regenicin Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Regenicin as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Regenicin's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Regenicin's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Regenicin.
Other Information on Investing in Regenicin Pink Sheet
Regenicin financial ratios help investors to determine whether Regenicin Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Regenicin with respect to the benefits of owning Regenicin security.